Home - Products - Angiogenesis - EGFR - Dehydroabietic acid

Dehydroabietic acid

CAS No. 1740-19-8

Dehydroabietic acid( —— )

Catalog No. M18122 CAS No. 1740-19-8

Dehydroabietic acid (DAA) is an EBV-EA activation inhibitor.

Purity : >98% (HPLC)

COA

Datasheet

HNMR

HPLC

MSDS

Handing Instructions

Size	Price / USD	Stock	Quantity
1 mL x 10 mM in DMSO	59	In Stock
2MG	33	In Stock
5MG	52	In Stock
10MG	92	In Stock
25MG	174	In Stock
50MG	257	In Stock
100MG	369	In Stock
200MG	Get Quote	In Stock
500MG	871	In Stock
1G	Get Quote	In Stock

Get Quotation Bulk Inquiry Add to Cart

Biological Information

Product Name

Dehydroabietic acid
Note

Research use only, not for human use.
Brief Description

Dehydroabietic acid (DAA) is an EBV-EA activation inhibitor.
Description

Dehydroabietic acid (DAA) is an EBV-EA activation inhibitor. DAA is a useful food-derived compound for treating obesity-related diseases, by decreasing plasma glucose, insulin levels, plasma triglyceride (TG) , and hepatic TG levels. DAA derivatives displays anti-secretory and anti-pepsin effect in animal models.
In Vitro

——
In Vivo

——
Synonyms

——
Pathway

Angiogenesis
Target

EGFR
Recptor

EBV
Research Area

Others-Field
Indication

——

Chemical Information

CAS Number

1740-19-8
Formula Weight

300.44
Molecular Formula

C20H28O2
Purity

>98% (HPLC)
Solubility

In Vitro:?DMSO : 100 mg/mL (332.85 mM)
SMILES

CC(C)C1=CC2=C(C=C1)C3(CCCC(C3CC2)(C)C(=O)O)C
Chemical Name

——

Shipping & Storage Information

Storage

(-20℃)
Shipping

With Ice Pack
Stability

≥ 2 years

Reference

Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog

related products

A-935142

A-935142 is a human ether-a-go-go-related gene (hERG, Kv 11.1) channel activator that enhances hERG currents by slowing inactivation, promoting activation, reducing inactivation, and shortening atrial and ventricular repolarization in a complex manner.
Cavutilide

Cavutilide has antiarrhythmic activity, inhibits hERG K(+) channels, and can be used to study heart failure and persistent atrial fibrillation.
Befotertinib

Befotertinib is an inhibitor of EGFR tyrosine kinase and can be used for studies about EGFR T790M-positive non-small cell lung cancer.

Sign In Join Free